POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS

Clinical trials for POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS explained in plain language.

Never miss a new study

Get alerted when new POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS trials appear

Sign up with your email to follow new studies for POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to stop cervical cancer recurrence in high-risk patients

Disease control Recruiting now

This study tests whether adding the drug serplulimab to standard chemoradiotherapy after surgery can help prevent cervical cancer from returning in patients with multiple risk factors. About 134 women aged 18-65 with PD-L1 positive cervical cancer will be randomly assigned to rec…

Matched conditions: POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 16, 2026 12:48 UTC

POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS

Get alerted when new POSTOPERATIVE CERVICAL CANCER WITH MULTIPLE RISK FACTORS trials appear

New drug combo aims to stop cervical cancer recurrence in high-risk patients